Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 3;11(9):e045882.
doi: 10.1136/bmjopen-2020-045882.

Seasonality of adverse birth outcomes in women with and without HIV in a representative birth outcomes surveillance study in Botswana

Ellen C Caniglia  1 , Jasmyn Abrams  2 , Modiegi Diseko  3 , Gloria Mayondi  3 , Judith Mabuta  3 , Joseph Makhema  3 , Mompati Mmalane  3 , Shahin Lockman  3   4 , Aaron Bernstein  5 , Rebecca Zash  6 , Roger Shapiro  3   5
Affiliations

Seasonality of adverse birth outcomes in women with and without HIV in a representative birth outcomes surveillance study in Botswana

Ellen C Caniglia et al. BMJ Open. .

Abstract

Introduction: Sub-Saharan Africa has the largest number of people with HIV, one of the most severe burdens of adverse birth outcomes globally and particular vulnerability to climate change. We examined associations between seasonality and adverse birth outcomes among women with and without HIV in a large geographically representative birth outcomes surveillance study in Botswana from 2015 to 2018.

Methods: We evaluated stillbirth, preterm delivery, very preterm delivery, small for gestational age (SGA), very SGA, and combined endpoints of any adverse or severe birth outcome. We estimated the risk of each outcome by month and year of delivery, and adjusted risks ratios (ARRs) of outcomes during the early wet (1 November-15 January), late wet (16 January-31 March) and early dry (1 April-15 July) seasons, compared with the late dry (16 July-31 October) season. Analyses were conducted overall and separately by HIV status.

Results: Among 73 178 women (24% with HIV), the risk of all adverse birth outcomes peaked in November-January and reached low points in September. Compared with the late dry season, the ARRs for any adverse birth outcome were 1.03 (95% CI 1.00 to 1.06) for the early dry season, 1.08 (95% CI 1.04 to 1.11) for the early wet season and 1.07 (95% CI 1.03 to 1.10) for the late wet season. Comparing the early wet season to the late dry season, we found that ARRs for stillbirth and very preterm delivery were higher in women with HIV (1.23, 95% CI 0.96 to 1.59, and 1.33, 95% CI 1.10 to 1.62, respectively) than in women without HIV (1.07, 95% CI 0.91 to 1.26, and 1.19, 95% CI 1.04 to 1.36, respectively).

Conclusions: We identified a modest association between seasonality and adverse birth outcomes in Botswana, which was greatest among women with HIV. Understanding seasonal patterns of adverse birth outcomes and the role of HIV status may allow for mitigation of their impact in the face of seasonal extremes related to climate change.

Keywords: HIV & AIDS; epidemiology; obstetrics; perinatology; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Risk of each adverse birth outcome by month and year of delivery, Tsepamo 2015–2018.
Figure 2
Figure 2
Risk of each adverse birth outcome by month of delivery and HIV status, Tsepamo 2015–2018.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization . Every newborn: an action plan to end preventable deaths 2014.
    1. Chen JY, Ribaudo HJ, Souda S, et al. . Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 2012;206:1695–705. 10.1093/infdis/jis553 - DOI - PMC - PubMed
    1. Zash R, Souda S, Chen JY, et al. . Reassuring birth outcomes with Tenofovir/Emtricitabine/Efavirenz used for prevention of mother-to-child transmission of HIV in Botswana. J Acquir Immune Defic Syndr 2016;71:428–36. 10.1097/QAI.0000000000000847 - DOI - PMC - PubMed
    1. Townsend CL, Cortina-Borja M, Peckham CS, et al. . Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and ireland. AIDS 2007;21:1019–26. 10.1097/QAD.0b013e328133884b - DOI - PubMed
    1. Suy A, Martínez E, Coll O, et al. . Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006;20:59–66. 10.1097/01.aids.0000198090.70325.bd - DOI - PubMed

Publication types